Repligen Corp insider trading
RGENfinancial statementsForm 4 filings on EDGAR127 transactions since Nov 3, 2024
From August 6, 2026 to November 3, 2026, 0 insiders at Repligen Corp bought $0 of stock in the open market, and 1 sold $6M. Officers and directors accounted for $0 of purchases and $6M of sales. The last reported transaction was an award by Douglass Brian Robb on October 6, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 8, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $6MAug 6, 2026 – Nov 3, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 3, 2026. Insider data through Nov 3, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
127 transactions from November 3, 2024 to November 3, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Douglass Brian Robb | CHIEF PRODUCT OFFICER | award | 700 | $0.00 | — | 8,685 | Oct 8, 2026 |
| Oct 5, 2026 | Loeillot Olivier | Chief Executive Officer, Director | open-market sale10b5-1 | 1,333 | $178.75 | $238K | 45,788 | Oct 6, 2026 |
| Oct 5, 2026 | Loeillot Olivier | Chief Executive Officer, Director | option exercise | 4,202 | $154.96 | $651K | 49,990 | Oct 6, 2026 |
| Oct 5, 2026 | Loeillot Olivier | Chief Executive Officer, Director | open-market sale10b5-1 | 4,202 | $190.00 | $798K | 45,788 | Oct 6, 2026 |
| Oct 2, 2026 | Loeillot Olivier | Chief Executive Officer, Director | tax withholding | 1,248 | $181.70 | $227K | 47,121 | Oct 5, 2026 |
| Sep 25, 2026 | Garland Jason K | CFO | tax withholding | 421 | $189.68 | $80K | 18,408 | Sep 28, 2026 |
| Sep 24, 2026 | Loeillot Olivier | Chief Executive Officer, Director | option exercise | 8,404 | $154.96 | $1M | 56,773 | Sep 25, 2026 |
| Sep 24, 2026 | Loeillot Olivier | Chief Executive Officer, Director | open-market sale10b5-1 | 8,404 | $190.00 | $2M | 48,369 | Sep 25, 2026 |
| Sep 24, 2026 | Loeillot Olivier | Chief Executive Officer, Director | option exercise | 4,542 | $155.38 | $706K | 52,911 | Sep 25, 2026 |
| Sep 24, 2026 | Loeillot Olivier | Chief Executive Officer, Director | open-market sale10b5-1 | 4,542 | $190.00 | $863K | 48,369 | Sep 25, 2026 |
| Sep 21, 2026 | Loeillot Olivier | Chief Executive Officer, Director | option exercise | 5,426 | $141.79 | $769K | 53,795 | Sep 22, 2026 |
| Sep 21, 2026 | Loeillot Olivier | Chief Executive Officer, Director | open-market sale10b5-1 | 5,426 | $180.00 | $977K | 48,369 | Sep 22, 2026 |
| Sep 4, 2026 | Loeillot Olivier | Chief Executive Officer, Director | open-market sale10b5-1 | 3,035 | $165.90 | $504K | 48,369 | Sep 8, 2026 |
| Sep 3, 2026 | Loeillot Olivier | Chief Executive Officer, Director | tax withholding | 2,842 | $169.61 | $482K | 51,404 | Sep 8, 2026 |
| Sep 1, 2026 | Hughes Violetta | CHIEF ACCOUNTING OFFICER | tax withholding | 277 | $170.02 | $47K | 6,331 | Sep 2, 2026 |
| Aug 20, 2026 | Loeillot Olivier | Chief Executive Officer, Director | option exercise | 5,426 | $141.79 | $769K | 59,672 | Aug 21, 2026 |
| Aug 20, 2026 | Loeillot Olivier | Chief Executive Officer, Director | open-market sale10b5-1 | 5,426 | $180.00 | $977K | 54,246 | Aug 21, 2026 |
| Jul 16, 2026 | Garland Jason K | CFO | open-market sale10b5-1 | 530 | $150.00 | $80K | 18,829 | Jul 17, 2026 |
| Jun 25, 2026 | Garland Jason K | CFO | open-market sale10b5-1 | 733 | $145.00 | $106K | 19,359 | Jun 26, 2026 |
| May 14, 2026 | Madaus Martin D | Director | award | 995 | $0.00 | — | 6,581 | May 18, 2026 |
| May 14, 2026 | Konstantinov Konstantin | Director | award | 995 | $0.00 | — | 3,889 | May 18, 2026 |
| May 14, 2026 | Eglinton Manner Carrie | Director | award | 995 | $0.00 | — | 5,461 | May 18, 2026 |
| May 14, 2026 | Mhatre Rohin | Director | award | 995 | $0.00 | — | 5,014 | May 18, 2026 |
| May 14, 2026 | Pax Margaret | Director | award | 995 | $0.00 | — | 3,011 | May 18, 2026 |
| May 14, 2026 | Muir Glenn P | Director | award | 995 | $0.00 | — | 40,051 | May 18, 2026 |
| May 14, 2026 | Dawes Karen A | Director | award | 995 | $0.00 | — | 92,816 | May 18, 2026 |
| May 14, 2026 | Barthelemy Nicolas | Director | award | 995 | $0.00 | — | 5,436 | May 18, 2026 |
| May 7, 2026 | Muir Glenn P | Director | option exercise | 2,434 | $38.76 | $94K | 39,056 | May 8, 2026 |
| May 7, 2026 | Douglass Brian Robb | CHIEF PRODUCT OFFICER | tax withholding | 334 | $126.43 | $42K | 7,985 | May 8, 2026 |
| Apr 21, 2026 | Loeillot Olivier | Chief Executive Officer, Director | open-market sale10b5-1 | 3,832 | $140.00 | $536K | 54,246 | Apr 22, 2026 |
| Mar 5, 2026 | Hughes Violetta | CHIEF ACCOUNTING OFFICER | award | 2,466 | $0.00 | — | 6,608 | Sep 2, 2026 |
| Mar 5, 2026 | Kuriyel Ralf | Senior VP, R&D | award | 5,284 | $0.00 | — | 20,062 | Mar 23, 2026 |
| Mar 5, 2026 | Loeillot Olivier | Chief Executive Officer | award | 24,134 | $0.00 | — | 58,078 | Mar 23, 2026 |
| Mar 5, 2026 | Bylund James | Chief Operating Officer | award | 7,751 | $0.00 | — | 25,423 | Mar 23, 2026 |
| Mar 5, 2026 | Garland Jason K | CFO | award | 7,751 | $0.00 | — | 20,092 | Mar 23, 2026 |
| Mar 4, 2026 | Bylund James | Chief Operating Officer | award | 125 | $0.00 | — | 17,734 | Mar 5, 2026 |
| Mar 4, 2026 | Bylund James | Chief Operating Officer | tax withholding | 62 | $125.84 | $8K | 17,672 | Mar 5, 2026 |
| Mar 4, 2026 | Kuriyel Ralf | Senior VP, R&D | award | 125 | $0.00 | — | 14,820 | Mar 5, 2026 |
| Mar 4, 2026 | Kuriyel Ralf | Senior VP, R&D | tax withholding | 42 | $125.84 | $5K | 14,778 | Mar 5, 2026 |
| Mar 2, 2026 | Bylund James | Chief Operating Officer | tax withholding | 2,433 | $124.97 | $304K | 17,609 | Mar 3, 2026 |
| Mar 2, 2026 | Loeillot Olivier | Chief Executive Officer, Director | tax withholding | 1,610 | $124.97 | $201K | 33,944 | Mar 3, 2026 |
| Mar 2, 2026 | Hunt Anthony | Director | tax withholding | 9,897 | $124.97 | $1M | 89,062 | Mar 3, 2026 |
| Mar 2, 2026 | Garland Jason K | CFO | tax withholding | 715 | $124.97 | $89K | 12,341 | Mar 3, 2026 |
| Mar 2, 2026 | Kuriyel Ralf | Senior VP, R&D | tax withholding | 923 | $124.97 | $115K | 14,695 | Mar 3, 2026 |
| Mar 2, 2026 | Douglass Brian Robb | CHIEF PRODUCT OFFICER | tax withholding | 221 | $124.97 | $28K | 8,319 | Mar 3, 2026 |
| Feb 27, 2026 | Bylund James | Chief Operating Officer | tax withholding | 1,478 | $128.73 | $190K | 20,042 | Mar 3, 2026 |
| Feb 27, 2026 | Loeillot Olivier | Chief Executive Officer, Director | tax withholding | 344 | $128.73 | $44K | 35,554 | Mar 3, 2026 |
| Feb 27, 2026 | Garland Jason K | CFO | tax withholding | 327 | $128.73 | $42K | 13,056 | Mar 3, 2026 |
| Feb 27, 2026 | Kuriyel Ralf | Senior VP, R&D | tax withholding | 444 | $128.73 | $57K | 15,618 | Mar 3, 2026 |
| Dec 31, 2025 | Douglass Brian Robb | CHIEF PRODUCT OFFICER | award | 2,288 | $0.00 | — | 8,540 | Jan 12, 2026 |
Who the insiders are
Everyone who reported a transaction since November 3, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Loeillot Olivier | Chief Executive Officer, Director | Oct 5, 2026 | open-market sale | 45,788 | — | $8M (9) | 9 of 9 |
| Hunt Anthony | Director | Mar 2, 2026 | tax withholding | 89,062 | — | $7M (12) | 5 of 12 |
| Bylund James | Chief Operating Officer | Mar 5, 2026 | award | 25,423 | — | $331K (1) | 0 of 1 |
| Garland Jason K | CFO | Sep 25, 2026 | tax withholding | 18,408 | — | $186K (2) | 2 of 2 |
| Dawes Karen A | Director | May 14, 2026 | award | 92,816 | — | $44K (1) | 0 of 1 |
| Kuriyel Ralf | Senior VP, R&D | Mar 5, 2026 | award | 20,062 | — | — | — |
| Muir Glenn P | Director | May 14, 2026 | award | 40,051 | — | — | — |
| Douglass Brian Robb | CHIEF PRODUCT OFFICER | Oct 6, 2026 | award | 8,685 | — | — | — |
| Hughes Violetta | CHIEF ACCOUNTING OFFICER | Sep 1, 2026 | tax withholding | 6,331 | — | — | — |
| Madaus Martin D | Director | May 14, 2026 | award | 6,581 | — | — | — |
| Pax Margaret | Director | May 14, 2026 | award | 3,011 | — | — | — |
| Konstantinov Konstantin | Director | May 14, 2026 | award | 3,889 | — | — | — |
| Eglinton Manner Carrie | Director | May 14, 2026 | award | 5,461 | — | — | — |
| Mhatre Rohin | Director | May 14, 2026 | award | 5,014 | — | — | — |
| Barthelemy Nicolas | Director | May 14, 2026 | award | 5,436 | — | — | — |
Questions
Are Repligen Corp insiders buying or selling?
Over the twelve months to November 3, 2026, 5 insiders at Repligen Corp sold $15M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $15M. Only open-market purchases and sales are counted.
Who sold the most Repligen Corp stock in the last year?
Loeillot Olivier (Chief Executive Officer, Director) sold $8M in 9 open-market sales over the twelve months to November 3, 2026.
Do Repligen Corp executives sell under 10b5-1 plans?
16 of the 25 open-market sales in the last twelve months (64%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Repligen Corp
- Repligen Corp financial statements
- 2 tracked funds holding RGEN
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.